We have developed an open-source biatrial modelling pipeline that incorporates patient-specific factors to assess atrial fibrillation inducibility and predict outcomes within clinical timelines. We are now expanding this study to evaluate the effectiveness of different ablation techniques and anti-arrhythmic drug therapies using ECG-calibrated biatrial models to personalise therapeutic outcomes.
Further reading:
[1] Biatrial Modelling for In Silico Prediction of Atrial Fibrillation Inducibility
[2] Constructing bilayer and volumetric atrial models at scale